VolitionRx Limited (VNRX) Current Ratio
- Current ratio · latest quarter: Value 0.30×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.30× | Current assets / current liabilities. $4.09M ÷ $13.49M ≈ 0.30× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 4.09M USD | Assets, Current |
| Current obligations | 13.49M USD | Liabilities, Current |
| Cash and equivalents | 2.80M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 277.36K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 3.56M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 1.07M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.09M | $13.49M | $2.80M | (m) | $277.36K | (m) | $3.56M | $1.07M | 0.30× |
| 2026-03-31 | $4.52M | $13.57M | (m) | (m) | $252.24K | (m) | $3.72M | $940.26K | 0.33× |
| 2025-12-31 | $2.06M | $12.23M | (m) | (m) | $317.81K | (m) | $2.92M | $890.57K | 0.17× |
| 2025-09-30 | $1.33M | $11.42M | $200.00K | (m) | $309.08K | (m) | $3.11M | $913.58K | 0.12× |
| 2025-06-30 | $3.26M | $9.24M | $2.30M | (m) | $189.60K | (m) | $2.35M | $1.02M | 0.35× |
| 2025-03-31 | $3.29M | $8.27M | $2.60M | (m) | $187.83K | (m) | $3.01M | $862.48K | 0.40× |
| 2024-12-31 | $4.06M | $7.79M | $3.26M | (m) | $110.57K | (m) | $2.77M | $860.22K | 0.52× |
| 2024-09-30 | $6.80M | $30.28M | (m) | (m) | $312.61K | (m) | $2.49M | $965.02K | 0.22× |
| 2024-06-30 | $7.35M | $30.98M | (m) | (m) | $166.26K | (m) | $3.35M | $1.04M | 0.24× |
| 2024-03-31 | $13.47M | $31.49M | $11.77M | (m) | $133.50K | (m) | $3.53M | $1.15M | 0.43× |
| 2023-12-31 | $21.85M | $8.94M | $20.73M | (m) | $242.62K | (m) | $3.21M | $1.21M | 2.44× |
| 2023-09-30 | $12.20M | $17.65M | $10.81M | (m) | $34.44K | (m) | $3.06M | $1.26M | 0.69× |
| 2023-06-30 | $21.51M | $18.80M | $19.74M | (m) | $196.49K | (m) | $3.49M | $1.20M | 1.14× |
| 2023-03-31 | $11.96M | $17.24M | $10.01M | (m) | $118.59K | (m) | $2.99M | $1.12M | 0.69× |
| 2022-12-31 | $12.17M | $17.39M | $10.87M | (m) | $72.61K | (m) | $3.04M | $1.07M | 0.70× |
| 2022-09-30 | $17.67M | $16.98M | $16.42M | (m) | $5.49K | (m) | $2.47M | $1.06M | 1.04× |
| 2022-06-30 | $18.65M | $17.35M | $16.73M | (m) | $8.49K | (m) | $2.60M | $1.09M | 1.07× |
| 2022-03-31 | $25.96M | $17.51M | $23.73M | (m) | $72.37K | (m) | $2.21M | $1.33M | 1.48× |
| 2021-12-31 | $21.98M | $6.52M | $20.58M | (m) | $12.51K | (m) | $1.54M | $797.86K | 3.37× |
| 2021-09-30 | $24.42M | $5.85M | $22.90M | (m) | $19.57K | (m) | $1.18M | $759.51K | 4.17× |
| 2021-06-30 | $29.39M | $5.40M | $27.91M | (m) | $15.83K | (m) | $1.08M | $822.37K | 5.44× |
| 2021-03-31 | $34.67M | $6.00M | $33.06M | (m) | $14.24K | (m) | $1.46M | $840.56K | 5.78× |
| 2020-12-31 | $20.33M | $6.24M | $19.44M | (m) | $7.12K | (m) | $1.54M | $841.32K | 3.26× |
| 2020-09-30 | $22.16M | $4.32M | $20.93M | (m) | $573.00 | (m) | $849.15K | $765.15K | 5.13× |
| 2020-06-30 | $22.42M | $4.71M | $21.31M | (m) | $3.22K | (m) | $1.41M | $692.72K | 4.76× |
| 2020-03-31 | $13.10M | $4.63M | $11.97M | (m) | $242.00 | (m) | $1.49M | $612.65K | 2.83× |
| 2019-12-31 | $17.56M | $3.86M | $16.97M | (m) | $0.00 | (m) | $627.25K | $647.57K | 4.55× |
| 2019-09-30 | $20.31M | $3.24M | $19.70M | (m) | $16.03K | (m) | $509.28K | (m) | 6.26× |
| 2019-06-30 | $19.24M | $3.50M | $18.51M | (m) | (m) | (m) | $1.32M | $562.75K | 5.50× |
| 2019-03-31 | $17.07M | $2.67M | $16.17M | (m) | (m) | (m) | $602.14K | (m) | 6.40× |
| 2018-12-31 | $13.90M | $2.33M | (m) | (m) | (m) | (m) | $807.16K | $416.55K | 5.96× |
| 2018-09-30 | $17.06M | $2.67M | $16.37M | (m) | (m) | (m) | $857.12K | (m) | 6.38× |
| 2018-06-30 | $12.52M | $3.34M | $11.89M | (m) | (m) | (m) | $1.16M | (m) | 3.74× |
| 2018-03-31 | $14.91M | $2.61M | $14.26M | (m) | (m) | (m) | $445.06K | (m) | 5.70× |
| 2017-12-31 | $10.57M | $2.29M | $10.12M | (m) | (m) | (m) | $351.74K | (m) | 4.61× |
| 2017-09-30 | $14.26M | $2.83M | $13.84M | (m) | (m) | (m) | (m) | (m) | 5.03× |
| 2017-06-30 | $16.95M | $2.24M | $16.51M | (m) | (m) | (m) | (m) | (m) | 7.56× |
| 2017-03-31 | $18.99M | $2.27M | $18.47M | (m) | (m) | (m) | (m) | (m) | 8.38× |
| 2016-12-31 | $22.01M | $2.03M | $21.68M | (m) | (m) | (m) | $281.18K | (m) | 10.82× |
| 2016-09-30 | $12.91M | $2.02M | $12.53M | (m) | (m) | (m) | (m) | (m) | 6.39× |
| 2016-06-30 | $14.93M | $1.55M | $14.50M | (m) | (m) | (m) | (m) | (m) | 9.62× |
| 2016-03-31 | $17.43M | $1.44M | $17.01M | (m) | (m) | (m) | (m) | (m) | 12.08× |
| 2015-12-31 | $6.22M | $1.12M | $5.92M | (m) | (m) | (m) | (m) | (m) | 5.56× |
| 2015-09-30 | $7.26M | $1.09M | (m) | (m) | (m) | (m) | (m) | (m) | 6.69× |
| 2015-06-30 | $9.69M | $1.27M | (m) | (m) | (m) | (m) | (m) | (m) | 7.60× |
| 2015-03-31 | $11.33M | $996.57K | (m) | (m) | (m) | (m) | (m) | (m) | 11.37× |
| 2014-12-31 | $2.34M | $2.71M | (m) | (m) | (m) | (m) | (m) | (m) | 0.86× |
| 2014-09-30 | $2.67M | $7.58M | $2.42M | (m) | (m) | (m) | (m) | (m) | 0.35× |
| 2014-06-30 | $2.01M | $3.15M | $1.81M | (m) | (m) | (m) | (m) | (m) | 0.64× |
| 2014-03-31 | $2.91M | $5.19M | $2.80M | (m) | (m) | (m) | (m) | (m) | 0.56× |
| 2013-12-31 | $1.01M | $957.27K | (m) | (m) | (m) | (m) | (m) | (m) | 1.05× |
| 2013-09-30 | $816.74K | $585.41K | $473.48K | (m) | (m) | (m) | (m) | (m) | 1.40× |
| 2013-06-30 | $1.06M | $674.34K | $750.75K | (m) | (m) | (m) | (m) | (m) | 1.57× |
| 2013-03-31 | $797.91K | $945.92K | $410.87K | (m) | (m) | (m) | (m) | (m) | 0.84× |
| 2012-12-31 | $695.14K | $747.77K | (m) | (m) | (m) | (m) | (m) | (m) | 0.93× |
| 2012-09-30 | $709.46K | $476.76K | $315.28K | (m) | (m) | (m) | (m) | (m) | 1.49× |
| 2012-06-30 | $719.64K | $422.63K | $386.25K | (m) | $11.71K | (m) | (m) | (m) | 1.70× |
| 2012-03-31 | $604.39K | $576.62K | $217.81K | (m) | (m) | (m) | (m) | (m) | 1.05× |
| 2011-12-31 | $699.47K | $534.36K | $347.89K | (m) | (m) | (m) | (m) | (m) | 1.31× |
| 2010-12-31 | $65.15K | $1.45M | $47.48K | (m) | (m) | (m) | (m) | (m) | 0.04× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |